Annual EBITDA
-$84.47 M
-$15.13 M-21.82%
31 December 2023
Summary:
IO Biotech annual earnings before interest, taxes, depreciation & amortization is currently -$84.47 million, with the most recent change of -$15.13 million (-21.82%) on 31 December 2023. During the last 3 years, it has fallen by -$72.46 million (-603.02%). IOBT annual EBITDA is now -686.77% below its all-time high of -$10.74 million, reached on 31 December 2019.IOBT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$26.30 M
-$4.98 M-23.36%
30 September 2024
Summary:
IO Biotech quarterly earnings before interest, taxes, depreciation & amortization is currently -$26.30 million, with the most recent change of -$4.98 million (-23.36%) on 30 September 2024. Over the past year, it has dropped by -$3.01 million (-12.92%). IOBT quarterly EBITDA is now -934.17% below its all-time high of -$2.54 million, reached on 31 December 2020.IOBT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$89.37 M
-$3.01 M-3.48%
30 September 2024
Summary:
IO Biotech TTM earnings before interest, taxes, depreciation & amortization is currently -$89.37 million, with the most recent change of -$3.01 million (-3.48%) on 30 September 2024. Over the past year, it has dropped by -$7.77 million (-9.52%). IOBT TTM EBITDA is now -2467.48% below its all-time high of -$3.48 million, reached on 30 September 2020.IOBT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOBT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.8% | -12.9% | -9.5% |
| 3 y3 years | -603.0% | -498.4% | -82.8% |
| 5 y5 years | - | - | - |
IOBT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -603.0% | at low | -498.4% | at low | -82.8% | at low |
| 5 y | 5 years | -686.8% | at low | -934.2% | +31.3% | -2467.5% | at low |
| alltime | all time | -686.8% | at low | -934.2% | +31.3% | -2467.5% | at low |
IO Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$26.30 M(+23.4%) | -$89.37 M(+3.5%) |
| June 2024 | - | -$21.32 M(+6.7%) | -$86.36 M(-0.4%) |
| Mar 2024 | - | -$19.99 M(-8.2%) | -$86.71 M(+2.6%) |
| Dec 2023 | -$84.47 M(+21.8%) | -$21.77 M(-6.5%) | -$84.47 M(+3.5%) |
| Sept 2023 | - | -$23.29 M(+7.5%) | -$81.60 M(+10.7%) |
| June 2023 | - | -$21.66 M(+22.1%) | -$73.69 M(+4.8%) |
| Mar 2023 | - | -$17.75 M(-6.1%) | -$70.30 M(+1.4%) |
| Dec 2022 | -$69.34 M | -$18.90 M(+22.9%) | -$69.35 M(-3.1%) |
| Sept 2022 | - | -$15.38 M(-15.9%) | -$71.54 M(+18.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$18.28 M(+8.8%) | -$60.56 M(-24.8%) |
| Mar 2022 | - | -$16.80 M(-20.4%) | -$80.56 M(+19.5%) |
| Dec 2021 | -$67.45 M(+461.3%) | -$21.09 M(+379.8%) | -$67.45 M(+37.9%) |
| Sept 2021 | - | -$4.39 M(-88.5%) | -$48.90 M(+1.9%) |
| June 2021 | - | -$38.29 M(+941.5%) | -$47.99 M(+394.7%) |
| Mar 2021 | - | -$3.68 M(+44.6%) | -$9.70 M(+61.0%) |
| Dec 2020 | -$12.02 M(+11.9%) | -$2.54 M(-26.9%) | -$6.02 M(+73.1%) |
| Sept 2020 | - | -$3.48 M | -$3.48 M |
| Dec 2019 | -$10.74 M | - | - |
FAQ
- What is IO Biotech annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for IO Biotech?
- What is IO Biotech annual EBITDA year-on-year change?
- What is IO Biotech quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for IO Biotech?
- What is IO Biotech quarterly EBITDA year-on-year change?
- What is IO Biotech TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for IO Biotech?
- What is IO Biotech TTM EBITDA year-on-year change?
What is IO Biotech annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IOBT is -$84.47 M
What is the all time high annual EBITDA for IO Biotech?
IO Biotech all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.74 M
What is IO Biotech annual EBITDA year-on-year change?
Over the past year, IOBT annual earnings before interest, taxes, depreciation & amortization has changed by -$15.13 M (-21.82%)
What is IO Biotech quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IOBT is -$26.30 M
What is the all time high quarterly EBITDA for IO Biotech?
IO Biotech all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.54 M
What is IO Biotech quarterly EBITDA year-on-year change?
Over the past year, IOBT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$3.01 M (-12.92%)
What is IO Biotech TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IOBT is -$89.37 M
What is the all time high TTM EBITDA for IO Biotech?
IO Biotech all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.48 M
What is IO Biotech TTM EBITDA year-on-year change?
Over the past year, IOBT TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.77 M (-9.52%)